-- Company to file Investigational New Drug (IND) Application with the United States Food and Drug Administration (FDA) for Protexia(R) and plans to initiate Phase I clinical trial in September 2008
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.